OnKure Therapeutics Statistics
NASDAQ: OKURHealthcareBiotechnologyUSD
2.30-0.05 (-2.13%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
OnKure Therapeutics by the numbers
OnKure Therapeutics has a market capitalization of $93.1 million based on 40.50M shares outstanding. With trailing EPS of $-3.04, OnKure Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 32.9% below its 50-day average and 37.0% below its 200-day average.
Average daily trading volume is 216.96K shares, or about $499,006 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
OKUR valuation vs. peer median
| Metric | OKUR | Peer median | Difference |
|---|---|---|---|
| Market cap | $93.14M | $90.78M | +3% |
| Avg. volume | 216.96K | 393.55K | -45% |
Peer median across 8 companies: ATRA, EQ, RLYB, NMRA, CNXU, MIST, ICCC, BMEA.
Valuation
- Market cap
- $93.14M
- EPS (TTM)
- $-3.04
- Shares outstanding
- 40.50M
Price and trading
- Previous close
- 2.35
- Open
- 2.34
- Day range
- 2.13 – 2.46
- 52-week range
- 2.13 – 5.38
- 52-week change
- -24.34%
- Beta
- —
- Volume
- 519.58K
- Average volume
- 216.96K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 93.14M
- Forward Pe
- -1.51
- Eps
- -3.04
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.38
- Week52 Low
- 2.13
- Avg Volume
- 216.96K
- Shares Outstanding
- 40.50M
- Ma50
- 3.43
- Ma200
- 3.65
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -57.25%
- Pct From52w Low
- 7.98%